Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus

Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus

Vaccination is the most effective preventive measure to control the spread of COVID-19 and reduce associated complications. This study aims to evaluate the efficacy and safety of mRNA COVID-19 vaccines in patients with systemic lupus erythematosus (SLE). A total of 41 adult SLE patients receiving tw...

Full description

Bibliographic Details
Main Authors:	Ilaria Mormile, Francesca Della Casa, Angelica Petraroli, Alessandro Furno, Francescopaolo Granata, Giuseppe Portella, Francesca Wanda Rossi, Amato de Paulis
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Vaccines
Subjects:	anti-SARS-CoV-2 mRNA vaccines COVID-19 SARS-CoV-2 systemic lupus erythematosus vaccination
Online Access:	https://www.mdpi.com/2076-393X/10/8/1221

Similar Items

Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary Angioedema
by: Ilaria Mormile, et al.
Published: (2023-01-01)

Immunogenicity of the Two mRNA SARS-CoV-2 Vaccines in a Large Cohort of Dialysis Patients
by: Paraskevi Tsoutsoura, et al.
Published: (2022-11-01)

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
by: Taimoor Khan, et al.
Published: (2022-04-01)

Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPS<sup>TM</sup>) SARS-CoV-2 Vaccine
by: Brian Cieslewicz, et al.
Published: (2022-07-01)

Human Coronavirus Spike Protein Based Multi-Epitope Vaccine against COVID-19 and Potential Future Zoonotic Coronaviruses by Using Immunoinformatic Approaches
by: Zulqarnain Baloch, et al.
Published: (2022-07-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
by: Chunting He, et al.
Published: (2020-07-01)

SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients
by: Natacha Bordry, et al.
Published: (2023-07-01)

An Update on mRNA-Based Viral Vaccines
by: Subbiah Jeeva, et al.
Published: (2021-08-01)

SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case–Control Study
by: Ireri Thirión-Romero, et al.
Published: (2023-11-01)

COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing
by: Santiago Grau, et al.
Published: (2022-04-01)

Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
by: Ignasi Esteban, et al.
Published: (2023-12-01)

Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational studyResearch in context
by: Alejandro Jara, et al.
Published: (2023-05-01)

Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
by: Helen Parry, et al.
Published: (2021-08-01)

Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2
by: Robert Daniel Heinrich Markewitz, et al.
Published: (2022-04-01)

Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients
by: Paraskevi Tsoutsoura, et al.
Published: (2023-06-01)

Comparison of Immune Responses between Inactivated and mRNA SARS-CoV-2 Vaccines Used for a Booster Dose in Mice
by: Ning Luan, et al.
Published: (2023-06-01)

Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency
by: Pierpaolo Di Micco, et al.
Published: (2021-09-01)

Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients
by: Pierluigi Toniutto, et al.
Published: (2023-06-01)

Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection
by: Huang Liang, et al.
Published: (2022-12-01)

Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
by: Sophie Diexer, et al.
Published: (2023-11-01)

A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
by: Maryam Joudi, et al.
Published: (2022-03-01)

Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study
by: Giovanni Corrao, et al.
Published: (2022-02-01)

Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype
by: Steve Pascolo
Published: (2021-02-01)

Advances of Reverse Vaccinology for mRNA Vaccine Design against SARS-CoV-2: A Review of Methods and Tools
by: Maria Karolaynne da Silva, et al.
Published: (2023-10-01)

Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
by: Mina Psichogiou, et al.
Published: (2021-06-01)

Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age
by: Krzysztof Lukaszuk, et al.
Published: (2021-11-01)

mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19
by: Christina M. Kackos, et al.
Published: (2023-02-01)

Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial
by: Frédéric Vanhoutte, et al.
Published: (2022-01-01)

SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel
by: Annapaola Santoro, et al.
Published: (2023-04-01)

Efficacy, Safety and Immunogenicity of Anti-SARS-CoV-2 Vaccines in Patients with Cirrhosis: A Narrative Review
by: Konstantina Toutoudaki, et al.
Published: (2023-02-01)

Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab
by: Victoria Furer, et al.
Published: (2022-06-01)

Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review
by: Andreas G. Tofarides, et al.
Published: (2022-12-01)

Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model
by: Devanshi R. Patel, et al.
Published: (2024-03-01)

Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2
by: Nura A. Mohamed, et al.
Published: (2022-07-01)

Self-Reported SARS-CoV-2 Vaccination Is Consistent with Electronic Health Record Data among the COVID-19 Community Research Partnership
by: Ashley H. Tjaden, et al.
Published: (2022-06-01)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz Al-Fattah Yahaya, et al.
Published: (2023-02-01)

Is SARS-CoV-2 Vaccination of Subjects with a Prior History of Allergies Dangerous? Experiences in the Veneto Region of Italy
by: Silvia Cocchio, et al.
Published: (2023-03-01)

Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
by: J. Finsterer, et al.
Published: (2023-09-01)

Neuroretinitis after the second injection of a SARS-CoV-2-vaccine: A case report
by: Chaeyeon Lee, et al.
Published: (2022-09-01)